You just read:

Arena Pharmaceuticals Reports Positive Phase 2 Results from the OASIS Trial for Etrasimod in Patients with Ulcerative Colitis

News provided by

Arena Pharmaceuticals, Inc.

Mar 19, 2018, 16:01 ET